The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walsh, C. M.
Right arrow Articles by Clark, W. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walsh, C. M.
Right arrow Articles by Clark, W. R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

The Journal of Immunology, Vol 156, Issue 4 1436-1441, Copyright © 1996 by American Association of Immunologists


ARTICLES

Cell-mediated cytotoxicity results from, but may not be critical for, primary allograft rejection

CM Walsh, F Hayashi, DC Saffran, ST Ju, G Berke and WR Clark
Department of Biology, University of California, Los Angeles 90095, USA.

Tumor cells insensitive to lysis through the Fas and TNF pathways were injected either subcutaneously or into the peritoneal cavities of allogeneic perforin-less (P0) and perforin wild-type (P2) mice. In three of four cases, the tumors were rejected equally rapidly in both strains of mice. Rejection was accompanied by vigorous in vitro cytotoxicity in P2, but not in P0 mice. The rapid clearance of allografted cells in mice where all three known cytolytic pathways are seriously compromised raises important questions about the involvement of cell-mediated cytotoxicity, as defined by current assay techniques, in primary allograft rejection.


This article has been cited by other articles:


Home page
J. Immunol.Home page
P. F. Halloran, L. W. Miller, J. Urmson, V. Ramassar, L.-F. Zhu, N. M. Kneteman, K. Solez, and M. Afrouzian
IFN-{{gamma}} Alters the Pathology of Graft Rejection: Protection from Early Necrosis
J. Immunol., June 15, 2001; 166(12): 7072 - 7081.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. S. Diamond and R. G. Gill
An Essential Contribution by IFN-{gamma} to CD8+ T Cell-Mediated Rejection of Pancreatic Islet Allografts
J. Immunol., July 1, 2000; 165(1): 247 - 255.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Phan, A. W. McMahon, R. C. Nelson, J. F. Elliott, and A. G. Murray
Activated Lymphocytes Promote Endothelial Cell Detachment from Matrix: A Role for Modulation of Endothelial Cell {beta}1 Integrin Affinity
J. Immunol., October 15, 1999; 163(8): 4557 - 4563.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
E. R. Jensen, A. A. Glass, W. R. Clark, E. J. Wing, J. F. Miller, and S. H. Gregory
Fas (CD95)-Dependent Cell-Mediated Immunity to Listeria monocytogenes
Infect. Immun., September 1, 1998; 66(9): 4143 - 4150.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. M. Krams, M. Hayashi, C. K. Fox, J. C. Villanueva, K. J. Whitmer, W. Burns, C. O. Esquivel, and O. M. Martinez
CD8+ Cells Are Not Necessary for Allograft Rejection or the Induction of Apoptosis in an Experimental Model of Small Intestinal Transplantation
J. Immunol., April 15, 1998; 160(8): 3673 - 3680.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. M. Gardiner, A. O' Meara, and D. J. Reen
Differential Cytotoxicity of Cord Blood and Bone Marrow-Derived Natural Killer Cells
Blood, January 1, 1998; 91(1): 207 - 213.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.